Data-Driven Decision Making

Global agency IDX opens a Swiss office, a strategic move fueled by rising client demand for evidence-based, AI-powered marketing and PR strategies.

As enterprises move from AI experimentation to execution, the focus is shifting to a critical, overlooked element: the data. Here's why.

A major investment in natural killer cell immunotherapy aims to revolutionize treatment for Canada's most fatal women's cancer after decades of stagnation.

Leixir Dental Group is launching two specialized labs, betting on advanced tech and artistry to dominate the lucrative full-arch and cosmetic dentistry markets.

As modern parents face record isolation, one early education brand is launching a new campaign to rebuild community, one school at a time.

Kathryn Cullen joins NAPA Anesthesia as President of Clinical Services, bringing a track record of operational excellence to a challenging healthcare landscape.

New FDA clearance for Hepatoscope adds spleen exams and industry-first compliance, changing how clinicians manage liver disease at the point of care.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

A new software-only approach from Retia Medical promises to turn routine monitors into powerful cardiac tools, democratizing critical care without new hardware.

Riverwood Capital hires veteran Mac Hofeditz to lead capital formation, signaling a major push to fund its disciplined, AI-driven investment strategy.

A startup's radical new model, born from a family's health crisis, directs all pediatric revenue to fund rare disease research and support families.

A new partnership aims to create a continuous data stream from surgery to recovery, using AI to predict and prevent costly gastrointestinal complications.

The top men's natural grooming brand is launching a mineral SPF spray, aiming to solve a problem most men ignore: sun protection. Here’s why it might work.

A new partnership aims to accelerate data-driven innovation, tackle productivity gaps, and empower British manufacturers with advanced analytics.

The biotech firm's new genomic intelligence platform aims to de-risk development by providing the first-ever benchmarks for chromosomal integrity.

A new 'growth-governance' standard challenges the costly paid ad model, promising clinics sustainable growth through data integrity and patient loyalty.

For the first time, Canada's biggest cities are shrinking. New data reveals where people are going and what it means for every business and community.

U.S. health tech giant Inovalon joins the World Economic Forum, aiming to leverage its massive data platform to combat a looming global health worker shortage.

With a new CEO from Mars and an IPO-tested CFO, Golden Pet Brands signals a major play for dominance in the booming premium pet nutrition market.

With a 104B-parameter AI and soaring revenue, Diagens is industrializing diagnostics. Can its ambitious 'Model-as-a-Service' clear global regulatory barriers?